Long-term outcomes after haploidentical stem cell transplantation (haplo-SCT) for hematologic malignancies

Authors

Supawee Saengboon, The University of Texas MD Anderson Cancer Center
Jeremy Ramdial, The University of Texas MD Anderson Cancer Center
Neeraj Saini, The University of Texas MD Anderson Cancer Center
Amanda Olson, The University of Texas MD Anderson Cancer Center
Jin Im, The University of Texas MD Anderson Cancer Center
Chitra Hosing, The University of Texas MD Anderson Cancer Center
Uday Popat, The University of Texas MD Anderson Cancer Center
Elizabeth Shpall MD, The University of Texas MD Anderson Cancer Center
Richard Champlin, The University of Texas MD Anderson Cancer Center
Samer A. Srour, The University of Texas MD Anderson Cancer Center

Files

Abstract

View full abstract

DOI

https://doi.org/10.52519/00081

Publication Date

11-2022

Department

Stem Cell Transplantation and Cellular Therapy

Research Category

Clinical Data Science

Recommended Citation

Saengboon, Supawee; Ramdial, Jeremy; Saini, Neeraj; Olson, Amanda; Im, Jin; Hosing, Chitra; Popat, Uday; Shpall, Elizabeth MD; Champlin, Richard; and Srour, Samer A., "Long-term outcomes after haploidentical stem cell transplantation (haplo-SCT) for hematologic malignancies" (2022). Leading Edge of Cancer Research Symposium. 8.
doi:https://doi.org/10.52519/00081